永勝醫療(01612.HK)與美敦力訂立全球分銷協議
格隆匯11月29日丨永勝醫療(01612.HK)發佈公吿,2021年11月26 日,公司間接全資附屬永勝保健器材有限公司與美敦力(Medtronic,一家全球醫療科技的領導者)訂立分銷協議。
根據分銷協議,公司委聘美敦力為其inspiredTM加濕器(humidifier)及配件以及 inspiredTM高流量呼吸濕化治療儀(high flow oxygen therapy device)及配件的首選分銷商,在逾30個國家(包括美國、阿根廷、巴西、墨西哥、英國及印度尼西亞)分銷產品,惟須先獲得相關國家的監管批准,並有權分銷往其他地區。
美敦力將負責銷售、市場推廣及分銷產品。集團將負責支援這些活動,並負責產品設計、生產、品質及安全控制、法規、生命週期管理及滿足產品註冊後的市場營銷要求等。分銷協議的年期為5年,並可每次自動續期12個月。
公吿稱,訂立分銷協議實為集團成為呼吸道護理解決方案領先供應商的目標邁出重大一步。此協議不僅將進一步增加inspiredTM器械的裝機數量,更有助集團開拓新市場以及進一步開發與其相關及互補的技術。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.